Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

83results about How to "Reduce degeneration" patented technology

Cartilage targeting double-drug-loaded nano-microspheres with optical thermal response characteristic and preparation method and application thereof

The invention relates to a preparation method and application of cartilage targeting double-drug-loaded nano-microspheres with the optical thermal response characteristic. According to thecartilage targeting double-drug-loaded nano-microspheres with the optical thermal response characteristic, small-particle-size mesoporous polydopamine is used as a matrix, the matrix is sequentially subjected toa cyclic reaction with FeCl3. 6H2O and H3BTC, and the surface of the mesoporous polydopamine is modified to form a metal organic framework. After the synthesized MPDA-MOF (referred to as MPM hereinafter) nano-microspheres react with EDC and NHS solution, carboxyl groups on the surface of MOF are activated, and by connection with amino groups in type II collagen targeting peptide (WYRGRL), composite nano-microspheres (MPMW) of which surfaces are loaded with a cartilage targeting peptide are formed. Double factors of bilirubin (Br) and rapamycin (Rap) are correspondingly loaded in pore passagesof an MOF shell layer and the mesoporous polydopamine, and finally, the RB@MPMW is obtained. The nano-microspheres have the advantages of high optical thermal response characteristic, good biocompatibility, active cartilage targeting, delay on in-vivo cartilage degeneration and the like, and can be used for the targeted therapy of osteoarthritis cartilage degeneration.
Owner:SHANGHAI FIRST PEOPLES HOSPITAL

Memory alloy artificial cervical intervertebral disc

A memory alloy artificial cervical intervertebral disc comprises an artificial intervertebral disc body and a support plate sleeved with the artificial intervertebral disc body, wherein the artificial intervertebral disc body has conicity; drop preventing reverse stings are distributed on the upper and lower surfaces of the artificial intervertebral disc body; fixed branches are arranged at the two sides of the upper and lower surfaces; and drop preventing pawls are respectively arranged at the two ends at the inner side of each fixed branch. The intervertebral disc has simple process and shape, is easy to deform and insert, is stable in installation after complex, is convenient to use in operation, is secure and reliable in fixation, maintains the cervical vertebra motion range, reduces adjacent vertebral body complications, not only shortens the operation time and simplifies the operation, but also dispenses with bone removal and grafting, reduces more pains of the patient, maintains or increases the motion range of the vertebral articulations with lesions to some extent, avoids load of the adjacent vertebral articulations from increasing after fusion and fixation of the vertebral articulations with lesions, slows down degeneration of the adjacent vertebral articulations and realizes the aims of maintaining the movement functions and delaying and reducing secondary degeneration of the adjacent segments.
Owner:LANZHOU LANFEI MEDICAL INSTR

Aconite extract injection for treating osteoarthritis as well as preparation method and application of aconite extract injection

InactiveCN107485651ASignificant reliefSignificant analgesic effectAntipyreticAnalgesicsArthritisHigh pressure
The invention discloses an aconite extract injection for treating osteoarthritis as well as a preparation method and application of the aconite extract injection, and belongs to the technical field of traditional Chinese medicine production. The preparation method comprises the steps: weighing radix aconiti and radix aconiti kusnezoffii as raw materials, adding uniformly mixed medicine powder into an alcohol solution, performing sealed soaking, transferring into a high-pressure reaction kettle, performing pressurized extraction, performing depressurization, performing filtering, separating medicine liquid from a filter residue, adding 8-10 volume times of water into the filter residue, performing uniform mixing, transferring into the high-pressure reaction kettle, performing pressurized extraction, concentrating the two medicine liquids until no alcohol odor exists, performing filtering, adding absolute alcohol to allow the alcohol content to reach 75%, performing standing overnight, performing filtering, concentrating the medicine liquid until no alcohol odor exists, performing dilution with injection water to be 10 times, and performing encapsulation and sterilization to obtain the aconite extract injection. The aconite extract injection has the significant influence on MMP-3, ADAMTS, IL-1 beta, IL-18, TNF-alpha and the like, and is confirmed to have a protective effect on chondrocyte damage caused by arthritis.
Owner:HEILONGJIANG ACAD OF TCM

Compositions and methods for the treatment of krabbe and other neurodegenerative diseases

InactiveUS20120156180A1Toxicity is reduced and eliminatedReducing psychosine-induced axonopathyBiocideNervous disorderMetachromatic leukodystrophyGm1 ganglioside
Provided are compositions and methods for the treatment of Krabbe and other neurodegenerative diseases, including storage diseases such as GM1 gangliosidosis, Niemann-Pick disease, Tay-Sachs disease, Sandhoff disease, metachromatic leukodystrophy, Canavan disease, Pelizaeus-Merzbacher disease, and storage conditions facilitated by aging of lysosomal functions, which are associated with psychosine (and/or other storage material)-mediated axonal degeneration. Compositions and methods employ (1) one or more inhibitor of a phos-photransferase activity of one or more kinase(s) such as, for example, CDK5, P38, jnk, src, CK2, PKC, GSK3α and β; (2) one or more inhibitor of a phosphotransferase activity of one or more phosphatase(s) such as, for example, the Ser/Thr protein phosphatase PP1 and Tyr protein phosphatase PP2; one or more inhibitor of a caspase/calpain activity of one or more caspases such as caspase 3 and calpains such as calpain 1 and 2; and (4) one or more inhibitor of a sodium/calcium exchange protein such as, for example, NCX1. Inhibitors include small molecules, including the GSK3β inhibitor L803 and the NCX1 inhibitor flecainide, and siRNA molecules that downmodulate cellular levels of one or more mRNA, including siRNA that are capable of downmodulating the cellular expression of PP1. Inhibitors disclosed can cross the blood-brain barrier and, thus, are available to the central nervous system (CNS) and effective in reducing psychosine-mediated axonal degeneration.
Owner:THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS

Sustained release aspirin liposome hydrogel and preparation method as well as application of sustained release aspirin liposome hydrogel in preparing medicine for treating recurrent lumbar disc herniation

The invention discloses sustained release aspirin liposome hydrogel and a preparation method as well as application of the sustained release aspirin liposome hydrogel in preparing a medicine for treating recurrent lumbar disc herniation after discectomy. The sustained release aspirin liposome hydrogel comprises aspirin, lipidosome and gelatin methylacryloyl hydrogel; the effect and a possible mechanism of treating intervertebral disc degeneration caused by fiber ring defect by the sustained release aspirin liposome hydrogel are proved through observation of structural characteristics and mechanical characteristics of the sustained release aspirin liposome hydrogel and tests of the influence of an in vitro material on the inflammation of nucleus pulposus cells and in vivo rabbit fiber ring defect modeling; ASP-Lip+GelMA is proved to show excellent performance in the aspect of filling rabbit partial fiber ring defect part, maintaining the mechanical stability and controlling local inflammation and provides a new treatment prospect for preventing the recurrent lumbar disc herniation after partial discectomy.
Owner:THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV

Memory alloy artificial cervical intervertebral disc

A memory alloy artificial cervical intervertebral disc comprises an artificial intervertebral disc body and a support plate sleeved with the artificial intervertebral disc body, wherein the artificial intervertebral disc body has conicity; drop preventing reverse stings are distributed on the upper and lower surfaces of the artificial intervertebral disc body; fixed branches are arranged at the two sides of the upper and lower surfaces; and drop preventing pawls are respectively arranged at the two ends at the inner side of each fixed branch. The intervertebral disc has simple process and shape, is easy to deform and insert, is stable in installation after complex, is convenient to use in operation, is secure and reliable in fixation, maintains the cervical vertebra motion range, reduces adjacent vertebral body complications, not only shortens the operation time and simplifies the operation, but also dispenses with bone removal and grafting, reduces more pains of the patient, maintains or increases the motion range of the vertebral articulations with lesions to some extent, avoids load of the adjacent vertebral articulations from increasing after fusion and fixation of the vertebral articulations with lesions, slows down degeneration of the adjacent vertebral articulations and realizes the aims of maintaining the movement functions and delaying and reducing secondary degeneration of the adjacent segments.
Owner:LANZHOU LANFEI MEDICAL INSTR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products